Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome

A report of “Arbeitsgemeinschaft für pädiatrische nephrologie”

  • 46 Accesses

  • 30 Citations

Abstract

In a multicenter cooperative study the effectiveness and side-effects of two most widely used regimens for prolonged interrupted prednisone treatment were compared in children with frequently relapsing nephrotic syndrome: i.e., alternate-day prednisone vs. intermittent prednisone. Sixty-four children were admitted to the study, 30 of whom were allocated to an alternate-day, 34 to an intermittent group. Sixteen patients did not complete the full trial, which left 48 children for final evaluation (23 alternate-day, 25 intermittent). The protocol consisted of two 6-month periods. During the first 6 months patients received maintenance prednisone (alternate-day = 35 mg/m2/48 h, intermittent = 40 mg/m2 on 3 out of 7 days). During the second 6-month pericd no maintenance prednisone was administered unless a relapse occurred and was treated with a short course of prednisone. The alternate-day prednisone reduced the number of relapsers and the rate of relapses significantly as compared with the control period of the second 6 months. The intermittent prednisone, however, did not significantly lower the number of relapsers, but only the rate of relapses. In the alternate-day group the number of relapsers and the rate of relapses were significantly lower than in the intermittent group. Observation for toxic side-effects did not reveal any difference. It is concluded that an alternate-day regimen is preferable to the intermittent regimen, which should be abandoned in the treatment of children with the nephrotic syndrome.

This is a preview of subscription content, log in to check access.

References

  1. 1

    Abramowicz CM, Arneil GC, Barnett HL, Barron BA, Edelmann CM, Gordillo-P G, Greifer I, Hallman N, Kobayashi O, Tiddens HA (1970) Controlled trial of azathioprine in children with nephrotic syndrome. Lancet I:959–961

  2. 2

    Abramowicz CM, Edelmann CM, Spitzer A (1970) Dogma disputed: alternate-day steroid therapy in the nephrotic syndrome of childhood. J Pediatr 76:336–338

  3. 3

    Ackermann GC, Nolan CM (1968) Adrenocortical responsiveness after alternate-day corticosteroid therapy. N Engl J Med 278:405–409

  4. 4

    Adams DA, Gold EM, Gonick HC, Maxwell MH (1966) Adrenocortical function during intermittent corticosteroid therapy. Ann Intern Med 64:542–551

  5. 5

    Arbeitsgemeinschaft für Pädiatrische Nephrologie (1979) Alternate-day versus intermittent prednisone in frequently relapsing nephrotic syndrome. Lancet I:401–403

  6. 6

    Barnett HL, Schoeneman M, Bernstein J, Edelmann CM Jr (1978) Minimal change nephrotic syndrome. In: Edelmann CM (ed) Pediatric kidney disease. Little, Brown Comp, Boston, pp 695–711

  7. 7

    Brodehl J (1972) Steroide oder Zytostatika beim kindlichen nephrotischen Syndrom. Klin Pädiat 184:241–249

  8. 8

    Brodehl J (1977) Zum Wandel des Nephrose-Begriffs seit Noeggerath. Klin Pädiat 189:199–206

  9. 9

    Brodehl J, Krohn HP (1977) Steroid trial in frequently relapsing nephrotic syndrome in children. In: Kluthe R, Vogt A, Batsford SR (eds) Glomerulonephritis. Georg Thieme Publisher, Stuttgart, pp 210–215

  10. 10

    Churg J, Habib R, White RHR (1970) Pathology of the nephrotic syndrome in children. Lancet I:1299–1302

  11. 11

    Cox DR, Lewis PA (1966) The statistical analysis of series ofevents. Methuen, London

  12. 12

    Elders MJ, Wingfield BS, McNatt ML, Clarke JS, Hughes ER (1975) Glucocorticoid therapy in children. Effect on somatomedin secretion. Am J Dis Child 129:1393–1396

  13. 13

    Fleisher DS (1967) Pituitary-adrenal responsiveness after corticosteroid therapy in children with nephrosis. J Pediatr 70:54–59

  14. 14

    Fleisher JS, McCrory WW, Rapoport M (1960) The effect of intermittent doses of adrenocortical steroids on the statural growth of nephrotic children. J Pediatr 57:192–198

  15. 15

    Graber AL, Ney RL, Nicholson WE, Island DP, Liddle GW (1965) Natural history of pituitary-adrenal recovery following long-term suppression with cortico-steroids. J Clin Endocrinol Metab 25:11–16

  16. 16

    Habib R, Kleinknecht C, Royer P (1971) Le syndrome nephrotique primitif de l'enfant. Classification et etude anatomo-clinique de 406 observations. Arch Fr Pediatr 28: 277–319

  17. 17

    Harter JG, Hall AP, Bayles TB (1965) Physiologic studies with single doses of steroid analogs and the implications for long-term alternate-day steroid therapy. Arthr Rheuma 8:445

  18. 18

    Harter JC, Reddy WJ, Thorn GW (1963) Studies on an intermittent corticosteroid dosage regimen. N Engl J Med 269:591–596

  19. 19

    Holub DA, Jailer JW, Kitay JI, Frantz AG (1959) Direct and indirect estimation of pituitary adrenocorticotropin reserves in man following adrenal steroid therapy. J Clin Endicrinol Metab 19:1540–1552

  20. 20

    International Study of Kidney Disease in Children (1974) Prospective controlled trial of cyclophosphamide therapy in children with the nephrotic syndrome. Lancet II:423–427

  21. 21

    Internationl Study of Kidney Disease in Children (1978) Nephrotic syndrome in children: prediction of histopathology from clinical and laboratory characteristics at time of diagnosis. Kidney Int 13:159–165

  22. 22

    Jao W, Pollak VE, Norris SH, Lewy P, Pirani CL (1973) Lipoid nephrosis. An approach to the clinicopathologic analysis and dismemberment of idiopathic nephrotic syndrome with minimal glomerular changes. Medicine 52:445–468

  23. 23

    Lange K, Slobody L, Strang R (1953) Treatment of nephrotic syndrome with interrupted ACTH or oral cortisone therapy. Proc Soc Exp Biol Med 82:315–317

  24. 24

    Lange K, Strang R, Slobody LB, Wenk EJ (1957) The treatment of the nephrotic syndrome with steroids in children and adults. Arch Intern Med 99:760–770

  25. 25

    Lange K, Wassermann E, Slobody LB (1958) Prolonged intermittent steroid therapy for nephrosis in children and adults. JAMA 168:377–381

  26. 26

    Leisti S, Hallman N, Koskimies O, Perheentupa J, Rapola R, Vilska J (1977) Association of postmedication hypocortisolism with early first relapse of idiopathic nephrotic syndrome. Lancet II:795–796

  27. 27

    Leisti S, Koskimies O, Perheentupa J, Vilska J, Hallman N (1978) Idiopathic nephrotic syndrome: prevention of early relapse. Br Med J I:892

  28. 28

    Leisti S, Vilska J, Hallman N (1977) Adrenocortical insufficiency and relapsing in the idiopathic nephrotic syndrome of childhood. Pediatrics 60:334–342

  29. 29

    Livanou T, Ferriman D, James VHT (1967) Recovery of hypothalamo-pituitary-adrenal function after corticosteroid therapy. Lancet II:856–859

  30. 30

    Martin MM, Gaboardi F, Podolsky S, Raiti S, Calcagno PL (1968) Intermittent steroid therapy. Its effect on hypothalamic-pituitary adrenal function and the response of plasma growth hormone and insulin to stimulation. N Engl J Med 279:273–278

  31. 31

    Mühlendahl KE v, Weber B, Müller-Hess R, Korth-Schütz S, Helge H (1978) Glucocorticosteroids and growth hormone secretion under physiological conditions and in states of steroid excess. Eur J Pediatr 128:113–121

  32. 32

    Myles AB, Barcon PA, Daly JR (1971) Single daily dose corticosteroid treatment. Effect on adrenal function and therapeutic efficacy in various diseases. Ann Rheum Dis 30:149–153

  33. 33

    Sadeghi-Nejad A, Senior B (1969) Adrenal function, growth and insulin in patients treated with corticosteroids on alternate days. Pediatrics 43:277–283

  34. 34

    Schlesinger ER, Sultz HA, Mosher WE, Feldman JG (1968) The nephrotic syndrome. Its incidence and implications for the community. Am J Dis Child 116:623–632

  35. 35

    Siegel NJ, Kashgarian M, Spargo BH, Hayslett JP (1974) Minimal change and focal sclerotic lesions in lipoid nephrosis. Nephron 13:125–137

  36. 36

    Soyka LF (1967) Treatment of the nephrotic syndrome in childhood. Am J Dis Child 113:693–701

  37. 37

    Soyka LF, Saxena KM (1965) Alternate-day steroid therapy for nephrotic children. JAMA 192:225–230

  38. 38

    Thoenes W (1974) Pathomorphologische Prinzipien und Formen der Glomerulonephritis. Monatsschr Kinderheilkd 122:728–740

  39. 39

    Zurbrügg RP, Zimmermann E, Oetliker OH (1974) Adrenocortical function following long-term corticosteroid treatment. Helv Paediatr Acta 29:221–235

Download references

Author information

Additional information

Supported by grants of VW Foundation

Participating centers: Basle, Switzerland: Kinderspital (F. Egli) Berlin-West: Universitaets-Kinderklinik Gesamthochschule (H. Olbing, H. J. Bachmann) Frankfurt a. M.: Universitaets-Kinderklinik (J. Dippell) Freiburg i. Br.: Universitaets-Kinderklinik (F. Schidera) Hamburg: Universitaets_Kinderklinik (F. Bläker, H. Altrogge) Hannover: Kinderklinik der Medizinischen Hochschule (J. Brodehl, H.-P. Krohn) und Kinderhielanstalt (J. Natzschka) Heidelberg: Universitaets-Kinderklinik (K. Schärer, D. Müller-Wiefel) Homburg: Universitaets-Kinderklinik (D. Krämer) Munich: Universitaets-Kinderklinik (R. Joppich) Münster: Universitaets-Kinderklinik (L. Diekmann) Stuttgart: Olgaspital (W. Hagge) Pathologist: W. Thoenes (Mainz) Statistician: B. Schneider (Hannover) Central office: Hannover, Kinderklinik der Medizinischen Hochschule (J.B)

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Brodehl, J. Alternate-day prednisone is more effective than intermittent prednisone in frequently relapsing nephrotic syndrome. Eur J Pediatr 135, 229–237 (1981). https://doi.org/10.1007/BF00442096

Download citation

Key words

  • Minimal change nephrotic syndrome
  • Frequent relapsers
  • Alternate-day prednisone
  • Intermittent prednisone
  • Cooperative study